Cargando…

Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada

BACKGROUND: With legal access to medical cannabis in Canada since 2001, there is a need to fully characterize its use at both the individual and population levels. We draw on data from Canada’s largest cohort study of medical cannabis to identify the primary reasons for medical cannabis authorizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Cerina, Round, Jessica M., Klarenbach, Scott, Hanlon, John G., Hyshka, Elaine, Dyck, Jason R. B., Eurich, Dean T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186125/ https://www.ncbi.nlm.nih.gov/pubmed/34103058 http://dx.doi.org/10.1186/s12954-021-00509-0

Ejemplares similares

Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014–2017 in Ontario, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
por: Round, Jessica M., et al.
Publicado: (2020)

Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
por: Zongo, Arsene, et al.
Publicado: (2021)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019
por: Callaghan, Russell C., et al.
Publicado: (2022)

Appropriateness of COVID-19 public health guidelines for an Alberta First Nations community
por: Soprovich, Allison L., et al.
Publicado: (2022)

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada
por: Versluys, Kristen A., et al.
Publicado: (2022)

Mental health experiences with COVID-19 public health measures in an Alberta First Nations Community
por: Lee, Cerina, et al.
Publicado: (2022)

Analgesic Use Among Adults with a Trauma-Related Emergency Department Visit: A Retrospective Cohort Study from Alberta, Canada
por: Sevcik, Bill, et al.
Publicado: (2023)

Follow-up Care of Living Kidney Donors in Alberta, Canada
por: Lam, Ngan N., et al.
Publicado: (2018)

Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada
por: Houle, Sherilyn K. D., et al.
Publicado: (2019)

Frequent users of emergency departments and patient flow in Alberta and Ontario, Canada: an administrative data study
por: Chen, Anqi, et al.
Publicado: (2020)

Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada
por: Wiese, Jessica L., et al.
Publicado: (2022)

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
por: Necyk, Candace, et al.
Publicado: (2021)

938. Identifying Gaps in the Treatment of Hepatitis C in Patients Co-Infected with HIV in Edmonton, Alberta
por: Savaryn, Bohdan, et al.
Publicado: (2020)

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study
por: Sharma, Vishal, et al.
Publicado: (2019)

Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada
por: Sharma, Vishal, et al.
Publicado: (2021)

Mortality and Resource Use Among Individuals With Chronic Kidney Disease or Cancer in Alberta, Canada, 2004-2015
por: Tonelli, Marcello, et al.
Publicado: (2022)

A retrospective analysis of real-world use of the eaTracker® My Goals website by adults from Ontario and Alberta, Canada
por: Lieffers, Jessica R. L., et al.
Publicado: (2016)

The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study
por: Osman, Mohammed, et al.
Publicado: (2023)

Incremental costs of hospital-acquired complications in Alberta, Canada
por: Jackson, T, et al.
Publicado: (2011)

Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
por: Myran, Daniel Thomas, et al.
Publicado: (2022)

Characteristics of Adults With Type 2 Diabetes Mellitus by Category of Chronic Kidney Disease and Presence of Cardiovascular Disease in Alberta Canada: A Cross-Sectional Study
por: Tonelli, Marcello, et al.
Publicado: (2019)

Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study
por: Ng, Jeremy Y., et al.
Publicado: (2021)

Use of sodium–glucose cotransporter 2 inhibitors in Alberta adults with chronic kidney disease: a cross-sectional study identifying care gaps to inform knowledge translation
por: Lau, Darren, et al.
Publicado: (2023)

Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
por: Ritchie, Bruce, et al.
Publicado: (2022)

SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, December 25, 2019, to December 1, 2020
por: Fung, Isaac Chun-Hai, et al.
Publicado: (2021)

Outcomes Among Patients Hospitalized With Non–COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada
por: McAlister, Finlay A., et al.
Publicado: (2023)

Predicting falls-related admissions in older adults in Alberta, Canada: a machine-learning falls prevention tool developed using population administrative health data
por: Sharma, Vishal, et al.
Publicado: (2023)

Secondary School Nutrition Policy Compliance in Ontario and Alberta, Canada: A Follow-Up Study Examining Vending Machine Data from the COMPASS Study
por: Vine, Michelle M., et al.
Publicado: (2021)

Chronic disease surveillance in Alberta’s tomorrow project using administrative health data
por: Ye, Ming, et al.
Publicado: (2021)

Ontario, Quebec and Alberta lead record family medicine residency vacancies
por: Duong, Diana, et al.
Publicado: (2023)

Cannabis use for menopause in women aged 35 and over: a cross-sectional survey on usage patterns and perceptions in Alberta, Canada
por: Babyn, Katherine, et al.
Publicado: (2023)

Household transmission of Streptococcus pneumoniae, Alberta, Canada.
por: Kellner, J D, et al.
Publicado: (1999)

Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada
por: Tyrrell, Gregory J., et al.
Publicado: (2002)

Asthma-related productivity losses in Alberta, Canada
por: Thanh, Nguyen X, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3gm785qfdc40accpekb1bhp8fr